Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Champoux Jennifer sold 2,175 Monte Rosa Therapeutics, Inc. shares (Form 4)
Traded May 27, 2026 · Filed May 28, 2026
On May 27, 2026, Champoux Jennifer (Chief Operating Officer) sold 2,175 Monte Rosa Therapeutics, Inc. shares at US$20.00 for US$43,500 under a trading plan, leaving 62,371 shares. Filed May 28, 2026 (Form 4).
- Sold
- 2,175 shares
- Price
- US$20.00
- Value
- US$43,500
- Holding after
- 62,371 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | Option exercise | 2,175 | US$3.98 | 64,546 | Direct |
| May 27, 2026 | Common Stock | Sale | 2,175 | US$20.00 | 62,371 | Direct |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Champoux Jennifer
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Champoux Jennifer · Jul 16, 2026
- Form 4 · Champoux Jennifer · Jun 25, 2026
- Form 4 · Champoux Jennifer · Jun 18, 2026
- Form 4 · Champoux Jennifer · May 26, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Jul 8, 2026